Thrombin Receptor Modulators: Medicinal Chemistry, Biological Evaluation, and Clinical Application
- 13 October 2008
- book chapter
- Published by Springer Nature
- p. 205-236
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNature Immunology, 2007
- Inhibition of Angiogenesis by Small-Molecule Antagonists of Protease-Activated Receptor-1Seminars in Thrombosis and Hemostasis, 2007
- Characterization of a new peptide agonist of the protease-activated receptor-1Biochemical Pharmacology, 2007
- A novel therapeutic target in various lung diseases: Airway proteases and protease-activated receptorsPharmacology & Therapeutics, 2007
- Thrombin‐mediated hepatocellular carcinoma cell migration: Cooperative action via proteinase‐activated receptors 1 and 4Journal of Cellular Physiology, 2007
- Plasmin-mediated Activation of Platelets Occurs by Cleavage of Protease-activated Receptor 4Journal of Biological Chemistry, 2004
- Role of Thrombin in Angiogenesis and Tumor ProgressionSeminars in Thrombosis and Hemostasis, 2004
- Thrombin hypothesis of thrombus generation and vascular lesion formationThe American Journal of Cardiology, 1995
- Enhancement of Thrombin Receptor Activation by Thrombin Receptor-Derived Heptapeptide with para-Fluorophenylalanine in Place of PhenylalanineBiochemical and Biophysical Research Communications, 1993
- Structure-activity studies of the thrombin receptor activating peptideBiochemical and Biophysical Research Communications, 1992